Cargando…

Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial

BACKGROUND: Mild cognitive impairment (MCI) is a transitional state between normal ageing and dementia. Most MCI patients will progress to dementia within 5 years; therefore, early intervention for MCI is important for delaying the occurrence and progression of dementia. Yi Shen Fang (YSF) granules...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sha, Zhongwei, Zhao, Zhenghao, Li, Nana, Xiao, Shuyun, Li, Ou, Zhang, Jie, Li, Zhimin, Xu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068223/ https://www.ncbi.nlm.nih.gov/pubmed/37013520 http://dx.doi.org/10.1186/s12906-023-03940-x

Ejemplares similares

The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
por: Sha, Zhongwei, et al.
Publicado: (2020)

Pharmaceutical and pharmacological studies of Shen Ma Yi Zhi granule for prevention of vascular dementia: A review
por: Chang, Su-rui, et al.
Publicado: (2022)

QiHuangYiShen Granules Modulate the Expression of LncRNA MALAT1 and Attenuate Epithelial-Mesenchymal Transition in Kidney of Diabetic Nephropathy Rats
por: Yuan, Li-sha, et al.
Publicado: (2023)

Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
por: Tan, Zhuojing, et al.
Publicado: (2022)

Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes
por: Liang, Mingzhu, et al.
Publicado: (2022)

Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial
por: Yue, Shengnan, et al.
Publicado: (2019)

Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3–4 COPD: A Randomized Controlled Trial
por: Yu, Xue-Qing, et al.
Publicado: (2023)

Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016)

BuShenYiQi Granule Inhibits Atopic Dermatitis via Improving Central and Skin Hypothalamic -Pituitary -Adrenal Axis Function
por: Kong, Lingwen, et al.
Publicado: (2015)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis
por: Perera, Pathirage Kamal, et al.
Publicado: (2010)

Correction: BuShenYiQi Granule Inhibits Atopic Dermatitis via Improving Central and Skin Hypothalamic -Pituitary -Adrenal Axis Function
por: Kong, Lingwen, et al.
Publicado: (2015)

QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016)

QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats
por: Lv, Shichao, et al.
Publicado: (2021)

The Protective Effect of Yi Shen Juan Bi Pill in Arthritic Rats with Castration-Induced Kidney Deficiency
por: Zhao, Hongyan, et al.
Publicado: (2012)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
por: Lv, Shichao, et al.
Publicado: (2022)

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation
por: Lv, Shichao, et al.
Publicado: (2015)

Effectiveness and Safety of Bu Shen Kai Qiao Fang in the Treatment of Alzheimer’s Disease: Study Protocol for a Multicenter, Prospective, Real-World Clinical Trial
por: Xu, ZeYu, et al.
Publicado: (2023)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2018)

Vascular Pharmacology of Mokuboito (Mu-Fang-Yi-Tang) and Its Constituents on the Smooth Muscle and the Endothelium in Rat Aorta
por: Nishida, Seiichiro, et al.
Publicado: (2007)

A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
por: Zhou, Xue-Feng, et al.
Publicado: (2021)

Yi Shen An, a Chinese traditional prescription, ameliorates membranous glomerulonephritis induced by cationic bovine serum albumin in rats
por: Zhao, Yun-Li, et al.
Publicado: (2022)

Modulation of the Gut Microbiota by Shen-Yan-Fang-Shuai Formula Improves Obesity Induced by High-Fat Diets
por: Wang, Zhen, et al.
Publicado: (2020)

Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial–Mesenchymal Transition
por: Zhao, Yuan, et al.
Publicado: (2022)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
por: Su, Xiuhai, et al.
Publicado: (2022)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015)

Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation
por: Du, Qing-Hong, et al.
Publicado: (2020)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
por: Wang, Yule, et al.
Publicado: (2021)

A Chinese herbal decoction, Jian-Pi-Yi-Shen, regulates the expressions of erythropoietin and pro-inflammatory cytokines in cultured cells
por: Chen, Jianping, et al.
Publicado: (2018)

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

Jian-Pi-Yi-Shen decoction inhibits mitochondria-dependent granulosa cell apoptosis in a rat model of POF
por: Jiang, Xiao-Lin, et al.
Publicado: (2022)

Protective effects and regulatory mechanisms of Shen-shuai-yi recipe on renal fibrosis in unilateral ureteral obstruction-induced mice
por: Lin, Ping-lan, et al.
Publicado: (2023)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
por: Ding, Congyang, et al.
Publicado: (2022)

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
por: Shang, Hongcai, et al.
Publicado: (2013)

Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial
por: Peng, Nan, et al.
Publicado: (2014)

Chinese Herbal Complex ‘Bu Shen Jie Du Fang' (BSJDF) Modulated Autophagy in an MPP(+)-Induced Cell Model of Parkinson's Disease
por: Liu, Cuifang, et al.
Publicado: (2019)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
por: Qu, Miao, et al.
Publicado: (2015)

Zi Shen Wan Fang Attenuates Neuroinflammation and Cognitive Function Via Remodeling the Gut Microbiota in Diabetes-Induced Cognitive Impairment Mice
por: Shi, Jiangwei, et al.
Publicado: (2022)

Correction for: Jian-Pi-Yi-Shen decoction inhibits mitochondria-dependent granulosa cell apoptosis in a rat model of POF
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis
por: Wang, Yuxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tg3otg8a3eufpf3iipk8glbeb3